AJU IB Investment Company’s Sutro Biopharma STRO Stock Holding History

AJU IB Investment Company’s Portfolio STRO Stock Details STRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-17,500	Closed	-$436K	–	5
2026 Q1	$436K	Hold	17,500	–	–	1.43%	5
2025 Q4	$202K	Hold	17,500	–	–	0.89%	7
2025 Q3	$153K	Hold	17,500	–	–	0.13%	7
2025 Q2	$125K	Hold	17,500	–	–	0.14%	7
2025 Q1	$114K	Hold	17,500	–	–	0.14%	8
2024 Q4	$322K	Buy	+17,500	New	+$534K	0.31%	6
2022 Q3	$971K	Hold	17,500	–	–	1.66%	7
2022 Q2	$912K	Hold	17,500	–	–	1.77%	7
2022 Q1	$1.44M	Hold	17,500	–	–	2.22%	7
2021 Q4	$2.6M	Hold	17,500	–	–	3.63%	6
2021 Q3	$3.31M	Hold	17,500	–	–	2.13%	5
2021 Q2	$3.25M	Hold	17,500	–	–	1.88%	5
2021 Q1	$3.98M	Hold	17,500	–	–	1.5%	5
2020 Q4	$3.8M	Buy	+17,500	New	+$2.9M	1.44%	5

Other funds holding STRO

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

AJU IB Investment Company's STRO Position: Q2 2026 in Review

AJU IB Investment Company sold out of Sutro Biopharma (STRO) in Q2 2026, closing a stake of 17,500 shares — an estimated $436K sold.

AJU IB Investment Company first reported a position in STRO in Q4 2020 and held it in 14 quarters. The position peaked at $3.98M in Q1 2021. 100 funds tracked by Wall St. Rank hold STRO as of Q2 2026.

AJU IB Investment Company reported no remaining Sutro Biopharma position as of Q2 2026 after selling out during the quarter.
AJU IB Investment Company sold 17,500 Sutro Biopharma shares in Q2 2026, an estimated $436K.
AJU IB Investment Company first reported a position in Sutro Biopharma in Q4 2020 and held it in 14 quarters.
AJU IB Investment Company's Sutro Biopharma position peaked at $3.98M in Q1 2021.
100 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2026.

Based on AJU IB Investment Company's 13F filing for Q2 2026.